BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 30361512)

  • 1. RhoGAP domain-containing fusions and PPAPDC1A fusions are recurrent and prognostic in diffuse gastric cancer.
    Yang H; Hong D; Cho SY; Park YS; Ko WR; Kim JH; Hur H; Lee J; Kim SJ; Kwon SY; Lee JH; Park DY; Song KS; Chang H; Ryu MH; Cho KS; Kang JW; Kook MC; Thiessen N; He A; Mungall A; Han SU; Kim HK
    Nat Commun; 2018 Oct; 9(1):4439. PubMed ID: 30361512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recurrent Fusion Genes in Gastric Cancer: CLDN18-ARHGAP26 Induces Loss of Epithelial Integrity.
    Yao F; Kausalya JP; Sia YY; Teo AS; Lee WH; Ong AG; Zhang Z; Tan JH; Li G; Bertrand D; Liu X; Poh HM; Guan P; Zhu F; Pathiraja TN; Ariyaratne PN; Rao J; Woo XY; Cai S; Mulawadi FH; Poh WT; Veeravalli L; Chan CS; Lim SS; Leong ST; Neo SC; Choi PS; Chew EG; Nagarajan N; Jacques PÉ; So JB; Ruan X; Yeoh KG; Tan P; Sung WK; Hunziker W; Ruan Y; Hillmer AM
    Cell Rep; 2015 Jul; 12(2):272-85. PubMed ID: 26146084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recurrent RhoGAP gene fusion CLDN18-ARHGAP26 promotes RHOA activation and focal adhesion kinase and YAP-TEAD signalling in diffuse gastric cancer.
    Zhang F; Sahu V; Peng K; Wang Y; Li T; Bala P; Aitymbayev D; Sahgal P; Schaefer A; Der CJ; Ryeom S; Yoon S; Sethi N; Bass AJ; Zhang H
    Gut; 2024 Apr; ():. PubMed ID: 38621923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of frequent CLDN18-ARHGAP26/6 fusion in gastric signet-ring cell cancer.
    Shu Y; Zhang W; Hou Q; Zhao L; Zhang S; Zhou J; Song X; Zhang Y; Jiang D; Chen X; Wang P; Xia X; Liao F; Yin D; Chen X; Zhou X; Zhang D; Yin S; Yang K; Liu J; Fu L; Zhang L; Wang Y; Zhang J; An Y; Cheng H; Zheng B; Sun H; Zhao Y; Wang Y; Xie D; Ouyang L; Wang P; Zhang W; Qiu M; Fu X; Dai L; He G; Yang H; Cheng W; Yang L; Liu B; Li W; Dong B; Zhou Z; Wei Y; Peng Y; Xu H; Hu J
    Nat Commun; 2018 Jun; 9(1):2447. PubMed ID: 29961079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enrichment of CLDN18-ARHGAP fusion gene in gastric cancers in young adults.
    Nakayama I; Shinozaki E; Sakata S; Yamamoto N; Fujisaki J; Muramatsu Y; Hirota T; Takeuchi K; Takahashi S; Yamaguchi K; Noda T
    Cancer Sci; 2019 Apr; 110(4):1352-1363. PubMed ID: 30771244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequent
    Tanaka A; Ishikawa S; Ushiku T; Yamazawa S; Katoh H; Hayashi A; Kunita A; Fukayama M
    Oncotarget; 2018 Jun; 9(50):29336-29350. PubMed ID: 30034621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RHOA mutations and CLDN18-ARHGAP fusions in intestinal-type adenocarcinoma with anastomosing glands of the stomach.
    Hashimoto T; Ogawa R; Tang TY; Yoshida H; Taniguchi H; Katai H; Oda I; Sekine S
    Mod Pathol; 2019 Apr; 32(4):568-575. PubMed ID: 30425335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of Transforming Growth Factor Beta 1 Signaling in Gastric Cancer-associated Fibroblasts Increases Their Motility, via Expression of Rhomboid 5 Homolog 2, and Ability to Induce Invasiveness of Gastric Cancer Cells.
    Ishimoto T; Miyake K; Nandi T; Yashiro M; Onishi N; Huang KK; Lin SJ; Kalpana R; Tay ST; Suzuki Y; Cho BC; Kuroda D; Arima K; Izumi D; Iwatsuki M; Baba Y; Oki E; Watanabe M; Saya H; Hirakawa K; Baba H; Tan P
    Gastroenterology; 2017 Jul; 153(1):191-204.e16. PubMed ID: 28390866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PPP1R1B-STARD3 chimeric fusion transcript in human gastric cancer promotes tumorigenesis through activation of PI3K/AKT signaling.
    Yun SM; Yoon K; Lee S; Kim E; Kong SH; Choe J; Kang JM; Han TS; Kim P; Choi Y; Jho S; Yoo H; Bhak J; Yang HK; Kim SJ
    Oncogene; 2014 Nov; 33(46):5341-7. PubMed ID: 24276243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of fusion genes in common and rare epithelial ovarian cancer histologic subtypes.
    Earp MA; Raghavan R; Li Q; Dai J; Winham SJ; Cunningham JM; Natanzon Y; Kalli KR; Hou X; Weroha SJ; Haluska P; Lawrenson K; Gayther SA; Wang C; Goode EL; Fridley BL
    Oncotarget; 2017 Jul; 8(29):46891-46899. PubMed ID: 28423358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Significance of the
    Zhang WH; Zhang SY; Hou QQ; Qin Y; Chen XZ; Zhou ZG; Shu Y; Xu H; Hu JK
    Front Oncol; 2020; 10():1214. PubMed ID: 32983960
    [No Abstract]   [Full Text] [Related]  

  • 12. The landscape and therapeutic relevance of cancer-associated transcript fusions.
    Yoshihara K; Wang Q; Torres-Garcia W; Zheng S; Vegesna R; Kim H; Verhaak RG
    Oncogene; 2015 Sep; 34(37):4845-54. PubMed ID: 25500544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expanding the molecular signature of ossifying fibromyxoid tumors with two novel gene fusions: CREBBP-BCORL1 and KDM2A-WWTR1.
    Kao YC; Sung YS; Zhang L; Chen CL; Huang SC; Antonescu CR
    Genes Chromosomes Cancer; 2017 Jan; 56(1):42-50. PubMed ID: 27537276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FGFR1/3 tyrosine kinase fusions define a unique molecular subtype of non-small cell lung cancer.
    Wang R; Wang L; Li Y; Hu H; Shen L; Shen X; Pan Y; Ye T; Zhang Y; Luo X; Zhang Y; Pan B; Li B; Li H; Zhang J; Pao W; Ji H; Sun Y; Chen H
    Clin Cancer Res; 2014 Aug; 20(15):4107-14. PubMed ID: 24850843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recurrent TRIO Fusion in Nontranslocation-Related Sarcomas.
    Delespaul L; Lesluyes T; Pérot G; Brulard C; Lartigue L; Baud J; Lagarde P; Le Guellec S; Neuville A; Terrier P; Vince-Ranchère D; Schmidt S; Debant A; Coindre JM; Chibon F
    Clin Cancer Res; 2017 Feb; 23(3):857-867. PubMed ID: 27528700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EWSR1 Fusions With CREB Family Transcription Factors Define a Novel Myxoid Mesenchymal Tumor With Predilection for Intracranial Location.
    Kao YC; Sung YS; Zhang L; Chen CL; Vaiyapuri S; Rosenblum MK; Antonescu CR
    Am J Surg Pathol; 2017 Apr; 41(4):482-490. PubMed ID: 28009602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PGP9.5 methylation in diffuse-type gastric cancer.
    Yamashita K; Park HL; Kim MS; Osada M; Tokumaru Y; Inoue H; Mori M; Sidransky D
    Cancer Res; 2006 Apr; 66(7):3921-7. PubMed ID: 16585221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accuracy of Hereditary Diffuse Gastric Cancer Testing Criteria and Outcomes in Patients With a Germline Mutation in CDH1.
    van der Post RS; Vogelaar IP; Manders P; van der Kolk LE; Cats A; van Hest LP; Sijmons R; Aalfs CM; Ausems MG; Gómez García EB; Wagner A; Hes FJ; Arts N; Mensenkamp AR; van Krieken JH; Hoogerbrugge N; Ligtenberg MJ
    Gastroenterology; 2015 Oct; 149(4):897-906.e19. PubMed ID: 26072394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multi-omics analysis identifies pathways and genes involved in diffuse-type gastric carcinogenesis induced by E-cadherin, p53, and Smad4 loss in mice.
    Park JW; Kim MS; Voon DC; Kim SJ; Bae J; Mun DG; Ko SI; Kim HK; Lee SW; Kim DY
    Mol Carcinog; 2018 Jul; 57(7):947-954. PubMed ID: 29528141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ChildSeq-RNA: A next-generation sequencing-based diagnostic assay to identify known fusion transcripts in childhood sarcomas.
    Qadir MA; Zhan SH; Kwok B; Bruestle J; Drees B; Popescu OE; Sorensen PH
    J Mol Diagn; 2014 May; 16(3):361-70. PubMed ID: 24517889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.